Evidence map›Paper›PMID 27824601›Full record

ReviewThe European respiratory journal2016

Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice.

Mukund Uplekar, Sachin Atre, William A Wells, Diana Weil, Rafael Lopez, Giovanni Battista Migliori, Mario Raviglione

Abstract readReview
In one paragraph

Review in The European respiratory journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Impact of COVID-19 on tuberculosis notifications.Revista do Instituto de Medicina Tropical de Sao Paulo · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Tuberculosis elimination: where are we now?European respiratory review : an official journal of the European Respiratory Society · 2018
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mukund UplekarGlobal TB Programme, World Health Organization, Geneva, Switzerland uplekarm@who.int.
Sachin AtreJohns Hopkins Clinical Trials Unit, BJ Medical College, Pune, India.
William A WellsUS Agency for International Development, Washington, DC, USA.
Diana WeilGlobal TB Programme, World Health Organization, Geneva, Switzerland.
Rafael LopezWorld Health Organization Regional Office for Americas, Washington DC, USA.
Giovanni Battista MiglioriFondazione S. Maugeri Care and Research Institute, Tradate, Italy.ORCID 0000-0002-2597-574X
Mario RaviglioneGlobal TB Programme, World Health Organization, Geneva, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Mandatory tuberculosis (TB) notification is an important policy under the End TB Strategy, but little is known about its enforcement especially in high TB incidence countries. We undertook a literature search for selected high-incidence countries, followed by a questionnaire-based survey among key informants in countries with high-, intermediate- and low-TB incidence. Published literature on TB notification in high-incidence countries was limited, but it did illustrate some of the current barriers to notification and the importance of electronic systems to facilitate reporting by private providers. Required survey data were successfully gathered from 40 out of 54 countries contacted. TB is notifiable in 11 out of 15 high-incidence countries, all 16 intermediate-incidence countries, and all nine low-incidence countries contacted. TB case notification by public sector facilities is generally systematised, but few high-incidence countries had systems and tools to facilitate notification from private care providers. In the context of the new End TB Strategy aimed at eventual TB elimination, all countries should have TB on their national list of notifiable diseases. Enhancing the ease of notification by private providers is essential for effective implementation. To that effect, investing in strengthening disease surveillance systems and introducing digital tools to simplify notification are logical ways forward.

Indexed as

Disease NotificationGlobal HealthHealth PolicyHumansIncidenceTuberculosis

Identifiers

PMID27824601
PMCPMC5898941

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.